These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9572659)

  • 1. Angiocytotoxic therapy in human non-small cell lung cancer cell lines--advantage of combined effects of TNP-470 and SN-38.
    Satoh H; Ishikawa H; Fujimoto M; Fujiwara M; Yamashita YT; Yazawa T; Ohtsuka M; Hasegawa S; Kamma H
    Acta Oncol; 1998; 37(1):85-90. PubMed ID: 9572659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effects of TNP-470 and taxol in human non-small cell lung cancer cell lines.
    Satoh H; Ishikawa H; Fujimoto M; Fujiwara M; Yamashita YT; Yazawa T; Ohtsuka M; Hasegawa S; Kamma H
    Anticancer Res; 1998; 18(2A):1027-30. PubMed ID: 9615759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
    Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S
    J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of CPT-11 in combination with other anticancer agents in lung cancer cells.
    Pei XH; Nakanishi Y; Takayama K; Bai F; Kawasaki M; Tsuruta N; Mizuno K; Hara N
    Anticancer Drugs; 1997 Mar; 8(3):231-7. PubMed ID: 9095327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of CPT-11 and SN-38 activities in human lung cancer cells.
    van Ark-Otte J; Kedde MA; van der Vijgh WJ; Dingemans AM; Jansen WJ; Pinedo HM; Boven E; Giaccone G
    Br J Cancer; 1998 Jun; 77(12):2171-6. PubMed ID: 9649129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro schedule-dependent interaction between irinotecan and vinorelbine in NCI H460 non-small cell lung cancer cell line.
    Gauvin A; Bressolle F; Martineau P; Astre C; Pinguet F
    Anticancer Res; 2002; 22(2A):905-12. PubMed ID: 12014670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma.
    Teicher BA; Holden SA; Dupuis NP; Kakeji Y; Ikebe M; Emi Y; Goff D
    Breast Cancer Res Treat; 1995; 36(2):227-36. PubMed ID: 8534870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro sensitivity of human endometrial cancer cell lines to paclitaxel or irinotecan (CPT-11) in combination with other aniticancer drugs.
    Hiramatsu HP; Kikuchi Y; Seto H; Nagata I
    Anticancer Drugs; 2000 Aug; 11(7):573-8. PubMed ID: 11036961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo.
    Singh Y; Shikata N; Kiyozuka Y; Nambu H; Morimoto J; Kurebayashi J; Hioki K; Tsubura A
    Breast Cancer Res Treat; 1997 Aug; 45(1):15-27. PubMed ID: 9285113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.
    Beecken WD; Fernandez A; Panigrahy D; Achilles EG; Kisker O; Flynn E; Joussen AM; Folkman J; Shing Y
    Urology; 2000 Sep; 56(3):521-6. PubMed ID: 10962337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment with TNP-470 and 5-fluorouracil effectively inhibits growth of murine colon cancer cells in vitro and liver metastasis in vivo.
    Ogawa H; Sato Y; Kondo M; Takahashi N; Oshima T; Sasaki F; Une Y; Nishihira J; Todo S
    Oncol Rep; 2000; 7(3):467-72. PubMed ID: 10767353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents.
    Kakeji Y; Teicher BA
    Invest New Drugs; 1997; 15(1):39-48. PubMed ID: 9195288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination effects of cisplatin, vinorelbine and irinotecan in non-small-cell lung cancer cell lines in vitro.
    Mogi H; Hasegawa Y; Watanabe A; Nomura F; Saka H; Shimokata K
    Cancer Chemother Pharmacol; 1997; 39(3):199-204. PubMed ID: 8996520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antitumor activity of 9-nitro-camptothecin as a single agent and in combination with other antitumor drugs.
    Bernacki RJ; Pera P; Gambacorta P; Brun Y; Greco WR
    Ann N Y Acad Sci; 2000; 922():293-7. PubMed ID: 11193904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antitumor activity of the SN-38-incorporating polymeric micelles NK012 with S-1 in a mouse model of non-small cell lung cancer.
    Nagano T; Yasunaga M; Goto K; Kenmotsu H; Koga Y; Kuroda J; Nishimura Y; Sugino T; Nishiwaki Y; Matsumura Y
    Int J Cancer; 2010 Dec; 127(11):2699-706. PubMed ID: 20198621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNP-470 combined with nicardipine suppresses in vivo growth of PC-3, a human prostate cancer cell line.
    Arisawa C; Kageyama Y; Kawakami S; Kihara K
    Urol Oncol; 2002; 7(6):229-34. PubMed ID: 12504843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an anti-angiogenic agent, TNP-470, on the growth of oral squamous cell carcinomas.
    Ueda N; Kamata N; Hayashi E; Yokoyama K; Hoteiya T; Nagayama M
    Oral Oncol; 1999 Nov; 35(6):554-60. PubMed ID: 10705089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic action of apoptosis induced by eicosapentaenoic acid and TNP-470 on human breast cancer cells.
    Yamamoto D; Kiyozuka Y; Adachi Y; Takada H; Hioki K; Tsubura A
    Breast Cancer Res Treat; 1999 May; 55(2):149-60. PubMed ID: 10481942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicity.
    Loprevite M; Favoni RE; de Cupis A; Pirani P; Merlo F; Grossi F; Ardizzoni A
    Int J Oncol; 1999 Oct; 15(4):787-92. PubMed ID: 10493963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro schedule-dependent interaction between paclitaxel and SN-38 (the active metabolite of irinotecan) in human carcinoma cell lines.
    Kano Y; Akutsu M; Tsunoda S; Mori K; Suzuki K; Adachi KI
    Cancer Chemother Pharmacol; 1998; 42(2):91-8. PubMed ID: 9654107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.